New Jersey

Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer

HAMILTON, , July 19, 2018 /PRNewswire/ -- Genesis Drug Discovery & Development (GD3) the contract research organization (CRO) of Genesis Biotechnology Group® (GBG), has announced the appointment of Olesia Buiakova, ,…
Continue Reading »
New Jersey

MouthWatch Launches “Teledentistry Innovation Awards” to Recognize Innovators and Pioneers of Connected and Collaborative Dental Care

METUCHEN, , July 19, 2018 /PRNewswire/ -- MouthWatch, LLC a leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices, is launching the Teledentistry Innovation Awards. The…
Continue Reading »
New Jersey

Private Advisor Group’s Chief Compliance Officer, Pat Sullivan, Earns National Recognition for Philanthropy as a Finalist in the 2018 Invest in Others Awards

NEWTON, Mass., July 18, 2018 /PRNewswire/ -- Pat Sullivan, Managing Director of Private Advisor Group in Morristown, NJ has been announced as one of three national finalists for the Lifetime…
Continue Reading »